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Abstract
To understand prostate cancer (PCa) specialists’ views about prostate cancer support groups (PCSGs), a volunteer
sample of Canada-based PCa specialists (n = 150), including urologists (n = 100), radiation oncologists (n = 40),
and medical oncologists (n = 10) were surveyed. The 56-item questionnaire used in this study included six sets of
attitudinal items to measure prostate cancer specialists’ beliefs about positive and negative influences of PCSGs,
reasons for attending PCSGs, the attributes of effective PCSGs, and the value of face-to-face and web-based PCSGs. In
addition, an open-ended question was included to invite additional input from participants. Results showed that PCSGs
were positively valued, particularly for information sharing, education and psychosocial support. Inclusivity, privacy,
and accessibility were identified as potential barriers, and recommendations were made for better marketing PCSGs
to increase engagement. Findings suggest prostate cancer specialists highly valued the role and potential benefits of
face-to-face PCSGs. Information provision and an educational role were perceived as key benefits. Some concerns
were expressed about the ability of web-based PCSGs to effectively engage and educate men who experience prostate
cancer.
Keywords
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Introduction
In Western countries, prostate cancer (PCa) is the most
common male cancer (Australian Government, 2013;
Canadian Cancer Society, 2013; Centers for Disease
Control and Prevention, 2013). Affecting 1 in 7 men, the
incidence of PCa is increasing with an aging male population and improved screening (Canadian Cancer Society,
2013). Men are also living longer with PCa, and the death
rate continues to be low amid increases in the number of
men being diagnosed (Australian Government, 2013;
Canadian Cancer Society, 2011; Centers for Disease
Control and Prevention, 2013). In the absence of a known
modifiable cause, for many men, PCa will be a chronic
illness (Canadian Cancer Society, 2013; Jemal et al.,
2009; Remzi, Waldert, & Djavan, 2004). Diverse morbidities can accompany PCa and its treatments, including
erectile dysfunction and urinary incontinence; psychosocial supports are thus integral to the well-being of men
who have PCa and their families (Arrington, 2010;
Chapple & Ziebland, 2002; Charmaz, 1995; Fergus,
Gray, & Fitch, 2002a, 2002b; Gannon, Guerro-Blanco,
Patel, & Abel, 2010; Meuleman & Mulders, 2003; Navon

& Morag, 2003a, 2003b; Oliffe, 2005, 2006; Wall &
Kristjanson, 2005). Among an array of psychosocial
oncology options, prostate cancer support groups
(PCSGs) have prevailed as important community-based
resources in Canada and other Western countries
(Arrington, 2010; Arrington, Grant, & Vanderford, 2010;
Gray et al., 1999; Gray, Fitch, Davis, & Phillips, 1996;
Gray, Fitch, Davis, & Phillips, 1997; Gray, Fitch, Phillips,
Labrecque, & Fergus, 2000b; Matsunaga & Gotay, 2005;
Steginga et al., 2001; Zanchetta, Cognet, Xenocostas,
Aoki, & Talbot, 2007). However, the sustainability of
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volunteer-run PCSGs have been challenged by recruitment and leadership succession issues (Oliffe et al.,
2008). Relatedly, PCSGs diverse connections to cancer
agencies and health care providers can influence group
viability. For example, health care providers who share
information at PCSGs and/or refer patients to group
meetings can advance the effectiveness and reach of
PCSGs. While PCa specialists are an important health
care provider subgroup, well positioned to link with
PCSGs in a variety of ways the perceptions and practices
of PCa specialists regarding PCSGs are poorly understood. In addressing the research question, what are
Canada-based PCa specialists’ views about PCSGs? This
study and article offers some empirical insights to address
this knowledge gap and thoughtfully consider avenues
for maximizing the potential of PCSGs.

Background
In contrast to the diversity in clinical psychosocial PCa
programs, PCSGs are somewhat uniform in their provision of support, with both face-to-face and virtual groups
focusing on (1) educational presentations from medical
experts and/or (2) group discussions about treatment
options, disease management, and/or health promotion
(Oliffe, Gerbrandt, Bottorff, & Hislop, 2010; Seale,
Ziebland, & Charteris-Black, 2006; Thaxton, Emshoff, &
Guessous, 2005). Research indicates that men attend
PCSGs to learn about their disease and treatment options
and side effect management from other men who have
direct experience, as well as from an array of health care
providers (Arrington et al., 2010; Gray et al., 1997;
Klemm, Hurst, Dearholt, & Trone, 1999; Manne, 2002;
Oliffe et al., 2010; Seale et al., 2006; Smith, Crane, Byers,
& Nelson-Marten, 2002; Thaxton, Emshoff, & Guessous,
2005). Women partners also attend PCSGs (Bottorff et
al., 2008; Thaxton et al. 2005) and the group leaders can
comprise health care providers and survivors. Compared
with information provision, some have argued that
PCSGs are less equipped to support men’s emotional distress (Arrington et al., 2010; Coreil & Behal, 1999; Weber
& Sherwill-Navarro, 2005). Although experiencing significant psychosocial concerns in relation to being diagnosed, it has also been reported that men typically adopt
an “instrumental” coping style oriented to action and
focus on “functionality” more than “feelings” in the context of in-person and online PCSGs (Klemm et al., 2003;
Oliffe et al., 2010, Seale et al., 2006). So while many men
do share ordinarily private illness experiences at PCSGs
(Oliffe et al., 2010), research indicates that emotional
supports are secondary motivations for attendance
(Thaxton et al. 2005; Voerman et al., 2007).
The vast majority of PCSG research has focussed on
the benefits and barriers to attending group meetings.
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Previous work detailing benefits includes an interview
study of 12 men—most of whom had leadership roles in
PCSGs located at Winnipeg, Toronto, and Ottawa—
reporting that men derived a sense of meaning and purpose through attending PCSGs (Gray et al., 1997).
Similarly, a survey of men who attended a professionally
led, Montreal-based PCSG reported that the sharing of
PCa experiences gave men reassurance, helped alleviate
anxiety, and provided a positive outlook and perception
of being involved in their treatment (Gregoire,
Kalogeropoulos, & Corcos, 1997). The benefits described
in these studies are confirmed elsewhere wherein PCSGs
have been reported as useful in mitigating the psychosocial aspects of cancer by conveying information, empowering men with PCa, enhancing and facilitating
psychosocial adjustment, and helping men and their partners cope with life after a diagnosis and treatment of cancer (Arrington, 2003; Arrington et al., 2010; Cordova et
al., 2003; Gray et al., 1997; Katz et al., 2002; Manne,
2002; Steginga et al., 2001; Voerman et al., 2007; Walker,
2005; Weber et al., 2004; Zhang et al., 2008).
In terms of barriers to attending PCSGs, an interview
study with 34 Canadian men and their partners led Gray,
Fitch, Phillips, Labrecque, and Fergus (2000a) to suggest
PCSGs were poorly attended because men typically avoid
disclosure due to low perceived need for support, fear of
stigmatization, the need to minimize the threat of illness
to aid coping, practical necessities in the work place, and
the desire to avoid burdening others. Related to this,
US-based and Australian-based men’s misperceptions
that PCSG meetings were geared toward emotional support of the terminally ill (Krizek, Roberts, Ragan, Ferrara,
& Lord, 1999; Walker, 2005) and a sense of shame and
embarrassment about sharing personal information
(Smith et al., 2002; Weber, Roberts, & McDougall, 2000)
were identified as barriers to attending support groups.
There is also evidence that health care providers
strongly influence men’s interest in attending a “support”
group. For example, health care providers’ lack of awareness of PCSGs can be a barrier (Smith et al., 2002). A
survey questionnaire study of 1,224 attendees at
Australian-based PCSGs confirmed that the clinician’s
level of endorsement for men’s participation in PCSGs
strongly influenced them to attend (Steginga, Pinnock,
Gardiner, Dunn, & Gardiner, 2005). This finding led
researchers to conclude that clinicians are integral to the
development and implementation of support services for
men with PCa (Steginga et al., 2005). A subsequent study
of 36 clinicians (27 urologists and 9 radiation oncologists) by Steginga et al. (2007) identified that participants
were reluctant to refer patients to PCSGs, fearing that
biased viewpoints and misinformation within the groups
might contribute to men’s uncertainty and decisional
regret.
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In summary, there is consensus that PCSGs provide
important resources to men and their families; however,
group sustainability can be challenged by failing to attract
new attendees, which in turn reduces the capacity for
group leadership succession planning (Oliffe et al., 2008).
Related to this it seems that men’s resistance to attending
PCSGs might stem from concerns about how the groups
operate and the legitimacy of the resources that they provide. In this regard, PCa specialists are well positioned to
inform men about the availability of PCSGs. While PCa
specialists’ reliability for reporting what may or may not
motivate PCa patients to attend a support group is debatable, their collective views about PCSGs provide important insights to thoughtfully consider avenues for
maximizing the potential of PCSGs.

Subjects and Method
This study was approved by the University of British
Columbia’s Behavioural Research Ethics Board
Committee. The survey instrument to solicit the PCa specialists’ views was developed as a web-survey composed
of a 56-item questionnaire based on Steginga et al.’s
(2007) study tool. The survey items were first developed
from in-depth expert stakeholder interviews with 36 clinicians (27 urologists and 9 radiation oncologists) who
had provided care to men with PCa for a mean of 16
years. To confirm item relevance in an iterative approach
a follow-up paper-based survey applying a 5-point Likerttype scale was completed by 30 of these participants from
which key themes were identified. For the current study
incorporated were five demographic questions and six
sets of attitudinal items to measure beliefs about: positive
influences of PCSGs, negative influences of PCSGs, reasons for attending PCSGs, the attributes of effective
PCSGs, and the value of face-to-face and web-based
PCSGs. Each set of attitudinal items included five to nine
questions that were rated by respondents using a 5-point
Likert-type scale (where 1 = strongly disagree and 5 =
strongly agree). An open-ended question to provide additional information was also included. Reliabilities for the
current study ranged from .72 to .94. This instrument is
available on request.
In all, 150 PCa specialist respondents were recruited
via existing professional contacts and the Canadian
Urological Association. There was a nominal honorarium
of a $50 gift card of their choice, which was mailed to
respondents on receipt of the completed survey.
Descriptive statistics are reported. Median scores are
reported for ordinal Likert data. Responses to the openended questions were coded and content analyses performed to inductively derive broad descriptive categories.
Respondents included 100 urologists, 40 radiation oncologists, and 10 medical oncologists. Table 1 presents
descriptive data on the demographic and professional

characteristics of the sample. Of 150 respondents, 82.7%
(n = 124) were male and the majority of respondents
practiced in British Columbia (38.0%) and Ontario
(33.3%). Respondents worked in a variety of settings,
including hospitals and/or cancer centers. They ranged in
age from 26 to 86 years (mean age = 44.7 years) and had
an average of 13.8 years’ experience working with PCa
patients. The majority (62.0%) reported formally presenting information at PCSGs, and 78% indicated that they
had referred patients to PCSGs.

Results
Features of PCSGs That Positively Influence
Men’s Adjustment to PCa
Respondents provided ratings of seven features of PCSGs
that were potentially positive influences on men’s adjustment to PCa (Figure 1). Ratings of these features were
uniformly high (median of five). All seven characteristics
(i.e., community support, reassurance, social identity,
sharing experiences, emotional support, and providing
information) were identified as important benefits. While
friendship was rated the lowest of the items, sharing
experiences and emotional support were highlighted as
the strongest factors positively influencing men’s adjustment to PCa.

Features of PCSGs That Negatively Influence
Men’s Adjustment to PCa
Specialists rated nine items related to possible negative influences of PCSGs including, meeting with
dominant members who push their own views, dissemination of inaccurate information, hearing negative
experiences, creating conflict over treatment decisions, promoting a specific clinician, creating confusion, supplying irrelevant information, causing
confrontation, and promoting a single therapy (Figure 2).
PCSG meetings with dominant members, dissemination of inaccurate information, and hearing negative
experiences were identified as the three leading negative influences of PCSGs affecting men’s adjustment
to PCa. The median response for the other six items
was 3 (neutral) with no specific negative factors being
identified as particularly influential. In addition, some
negative influences were apparent in the open-ended
responses discussed below.

Reasons for Attending PCSGs
The items most strongly endorsed by PCa specialists as
the reasons that men attended PCSGs were to discuss PCa
treatments and to gain information (median of 5; see
Figure 3).
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Table 1. Demographic & Professional Characteristics of the
Study Sample.
Demographic characteristic

n (%)

Age in years (mean = 44.7, range = 26-86)
20-30
13 (8.7)
31-40
51 (34.0)
41-50
39 (26.0)
51-60
31 (20.6)
60+
15 (10.0)
Unspecified
1 (0.7)
Gender
Male
124 (82.7)
Female
26 (17.3)
Practice location (province)
Alberta
16 (10.7)
British Columbia
57 (38.0)
New Brunswick
3 (2.0)
Manitoba
5 (3.3)
Newfoundland
1 (0.7)
Nova Scotia
3 (2.0)
Ontario
50 (33.3)
Quebec
11 (7.3)
Saskatchewan
4 (2.7)
Years working with prostate cancer patients
1-10
73 (48.7)
11-20
43 (28.7)
21-30
23 (15.3)
31+
11 (7.3)
Linkages to PCSGs
Presenter at group
93 (62.0)
Referred patients to group
117 (78.0)
Group member
7 (4.7)
Group leader
1 (0.7)
No linkages
5 (3.3)
Other (n = 5)
   Web-based PCSG leader
   Receives weekly newsletter from
local group
   Spoken to patients about PCSGs
  PCSGs advisor
   Academic writing on prostate
cancer
Types of practice (respondents could endorse more than one
practice type)
Hospital
90 (60.0)
Cancer centre
60 (40.0)
Private
48 (32.0)
Note. Percentages may not total 100 because of rounding. PSCGs =
prostate cancer support groups.

Reasons for Not Attending PCSGs
Perceived reasons for not attending PCSGs were assessed
with seven items. Privacy issues was the most clearly
endorsed reason for not attending PCSGs (median of 5),

followed by ignorance of PCSGs (Figure 4). Items including “no need,” “having enough information,” and “a
desire to move past the PCa experience,” were also highly
endorsed by PCa specialists (median of 4) as reasons why
some men might prefer not to attend PCSGs.

Characteristics of Effective PCSGs
Respondents rated items to assess their views on the characteristics of effective face-to-face PCSGs. Avoiding bias
by not promoting one view of treatment, a range of different health care providers’ input, being patient-driven, and
diversity of therapies discussed were the most highly
endorsed characteristics of effective PCSGs (median rating of 5; Figure 5). Supported by other health care providers, having a trained facilitator, and support from
health organizations were also generally agreed as keys to
success (median rating of five).

Characteristics of Effective Web-Based PCSGs
Provision of summarized PCa information, the use of
multimedia evidence-based health care provider presentations, and the facilitation of camaraderie were identified as the most essential features of effective web-based
PCSGs (Figure 6). The findings suggest that specialists
are most concerned with the accuracy and interactive
capacity of the information made available online.

Additional Commentary
Thirty-four respondents shared additional insights via
written comments. Table 2 presents the results from the
content analysis of the open-text comments. In summary,
the main cautions related to online PCSGs and prostate
specific antigen advocacy. Online PCSGs were predicted
to encounter similar shortcomings, and they were suggested to augment rather than replace face-to-face meetings for a variety of reasons including older men’s
reduced access to online resources. In terms of endorsements and suggestions for promoting the work of PCSGs,
respondents offered a range of ideas, including messaging individual clinicians about the groups and supplying
brochures to clinics that patients could take with them.

Discussion
The results from the current study provide important
insights to PCa specialists’ awareness of the benefits of
PCSGs for men with regards to emotional support underpinned by the sharing of personal experience. Men are
typically underrepresented as seekers of psychological
support after cancer (Steginga et al., 2008) and a recent
U.S. study indicated that PCa patients are approximately
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Figure 1. Positive factors how prostate cancer support groups influence men’s adjustment to prostate cancer.
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Figure 2. Negative factors how prostate cancer support groups influence men’s adjustment to prostate cancer.

30% less likely than breast cancer patients to have discussed emotional and social concerns with their health
care provider (Forsythe et al., 2013). In light of these
findings it may be that although PCa specialists appear to
understand and endorse the benefits of face-to-face
PCSGs, emotional and social care, and therefore raising
patient awareness about support groups is not necessarily
a priority. That said, given that many men with PCa report
unmet needs for support with regards to fears about the
cancer returning or spreading and worry about “significant” others (Lintz et al., 2003; Smith et al., 2007;
Steginga et al., 2001), PCSGs present as a valuable but
potentially underused support program.
Contrasted within the current study findings that sharing experiences and emotional support were the most
positive influences of PCSGs on men’s adjustment, PCa
specialists rated information as men’s primary motivation

for attending groups. Interestingly, the key reasons
endorsed as potentially negative effects of support groups
including online groups, centered on misinformation.
This may reflect the uncertainty that persists about the
optimal treatment approach for PCa, the expanding array
of treatment options and regimes, and from this, clinicians concerns about supporting men’s decision making
in the clinical encounter. Men with PCa often report high
decisional conflict that for some persists over time
(Steginga, Occhipinti, Gardiner, Heathcote, & Yaxley,
2004), and men do report others cancer experiences, both
positive and negative, as influencing their treatment
choices (Steginga et al., 2002). Hence, this is a highly
salient clinical issue for specialists in these men’s care.
There was less agreement on the value of PCSG in
terms of social interaction and helping other men with
PCa, suggesting that some PCa specialists believe the
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Figure 3. Reasons why men choose to attend a prostate cancer support group.
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Figure 4. Reasons why men choose not to attend a prostate cancer support group.
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Figure 5. Key factors for the effectiveness of an in-person prostate cancer support group.

group format of PCSGs may be unappealing to men and
dissuade them from attending. These views may also sug-

gest that PCa specialists do not anticipate men to be longterm attendees.
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Figure 6. Key factors for the effectiveness of a web-based prostate cancer support group.
Table 2. Main Endorsements and Cautions From Open-Ended Question.
Endorsements
•• They have gradually transitioned over the years from
consisting of those with bad experiences looking for
support to those made up of men truly interested in
helping their peers.
•• They are important and should be available in all academic
centers across Canada.
•• Support groups are vital to the overall treatment of any
disease particularly malignancies such as prostate cancer.
•• Support groups of huge value to patients trying to make
initial decision.
•• I think it is worth making patients aware of so they can
choose to be involved if it’s right for them. I think it is
important that these types of things remain patient driven.
•• Need more awareness of such programs.
•• Web-based solutions should link prostate cancer support
groups across regions, to integrate smaller ones into bigger
ones for enhanced support.
•• A brochure that could be given out in clinic about support
groups would be helpful—they could take home and have
time to think about it and see what it’s about and reach
out on their own rather than getting a yes or no in clinic if
they are interested.
•• Please send individual practitioners more information
about support groups.
•• Prostate cancer support groups could also be used as a
forum for discussing other health problems, especially
cardiovascular diseases, since men with prostate cancer
are more likely to die from it than from prostate cancer.
•• I’ve enjoyed participating educating and presenting at
prostate cancer group.

Cautions
•• Generally great people, but are really dependent on the skills
of its members and limited by resources and contacts. I have
had concerns in the past about messaging going out about
prostate cancer screening from the support groups locally.
•• A group with an open approach is best. Not focusing on any
one treatment, or area. Avoid advocacy.
•• I think face-to-face contact is important with web-based
contact as an adjunct.
•• Web based and groups are for different populations, that
is, younger and older patients they also serve different
purposes the first for objective information and the second
for emotional support.
•• Anonymity of web-based forms are a two edged sword.
They do broaden the reach but allow for easier hijacking
by individuals/groups with agendas and biases (i.e., logging
on of an individual with more than one identity providing a
discussion which is really a directing monologue). In the web,
it is also harder to identify geographic variances (could be
both good and bad).
•• I personally feel that web-based support groups would be
difficult for our elderly patients (confusing). I favor group
meetings.
•• I have concerns about the quality and accessibility of web 2.0
options for support groups for many of our more elderly
patients—I think they do however have potential for a
strong role with our younger patients, families, and selected
older patient populations. My fear having presented to these
groups is that the range of disease is quite broad.
•• In our area, the average participant at our support group is
over 65, I am not sure they would participate to a web-based
support group.
•• I would think the benefits and goals of a web-based group
may be different from an in-person group, and I’d have more
concern about the web-based approach, regarding risks of
misinformation, miscommunication, hostility from anonymous
contributors, potential risks to confidentiality, etc. I wouldn’t
personally feel that a web-based utility would be the optimal
method for support group conduct or purposes.
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The overarching endorsement of specialists for faceto-face PCSGs suggest some shifts to Steginga et al.
(2007) findings which highlighted specialists’ concerns
about the potential for misinformation. Such subtle
changes are likely influenced by an array of factors
including specialists’ direct exposure to PCSGs, increased
clinical emphasis on shared treatment decision-making,
and the growth and research fundraising activities of
groups more generally. While specialists’ concerns about
misinformation may be more focused on web-based
resources including online PCSGs, face-to-face groups
may need to dissect out and better define and focus their
role in decision and information support if they are to further build specialist support and referral to their groups
and programs.
Although this study is explorative, identified were
some variations with respect to PCa specialist views
about PCSGs. These findings as well as views that a lack
of knowledge about PCSG might obscure PCSGs as a
potential resource for men indicate that efforts are needed
to raise awareness about PCSGs and its potential value in
targeted and tailored communications to PCa specialists
and men in the community. Engaging PCa survivors who
have attended PCSGs to challenge assumptions and misconceptions about PCSGs that are barriers to attendance
is likely to be helpful. The positive experiences of other
men can provide powerful examples to overcome fears
among potential attendees. However, a parallel educational initiative to ensure that PCa specialists are well
informed about PCSGs is also needed. The consideration
of PCa specialists’ personal perspective is essential in the
planning and implementation of this type of initiative.
The current study limitations include recognition that
the reliability of PCa specialists to report what may or
may not motivate patients to attend a PCSG is debatable.
Moreover, PCa specialists’ perspectives about PCSGs are
one among many potentially diverse health care provider
views. Therefore, acknowledged also are the limits in
terms of generalizability in describing the viewpoints of a
small Canada-based sample of a PCa specialists.
Nonetheless, these limitations provide important direction for future studies, which might include large international multisite studies integrating qualitative interviews
to more fully contextualize the findings offered in the
current study.
While the PCSG sustainability issues raised by Oliffe
et al. (2008) talked to the challenges connecting to nonprofit cancer agencies, the findings from the current study
reveal the PCa specialists as allies with significant potential for advancing PCSGs, especially by raising awareness with potential attendees. In this regard, formalizing
collaborations might be mutually beneficial whereby a
steady flow of new PCSG attendees can be mustered and
the burden on clinical psychosocial oncology services
further reduced.
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